Dr. Markus Rimann

Arbeit an der ZHAW

Tätigkeit

• Gruppenleiter 3D Gewebe und Biofabrikation
• Leiter TEDD Kompetenzzentrum
• Dozent in biologischen Fächern
• Angewandte Forschung in Tissue Engineering

Arbeits- und Forschungsschwerpunkte

• Tissue Engineering
• Bioprinting
• Biofabrikation
• Gerüst-frei und gerüst-basierte 3D Zellkulturmodelle
• Automatisierung von komplexen Zellkultursystemen
• Medikamentenentwicklung
• Regenerative Medizin

Lehrtätigkeit

• Zellbiologie
• Mikrobiologie
• Zell- und Gewebetherapie
• Praktikum in Zellbiologie

Berufserfahrung

• Gruppenleiter und Dozent
  ZHAW
  01 / 2011 - heute
• Postdoc
  Universität Zürich CABMM
  01 / 2010 - 12 / 2010
• Biologielaborant
  ETH Zurich
  08 / 1999 - 08 / 2001

Aus- und Weiterbildung

Ausbildung

• PhD / Biologie und Materialien
  ETH Zurich
  05 / 2006 - 12 / 2009
• MSc in Biologie / Biotechnologie
  ETH Zurich
  09 / 2001 - 08 / 2005
• Eidgenössisches Fahigkeitzeugnis als Biologielaborant (Lehre) / Biologie
  ETH Zurich
  08 / 1996 - 07 / 1999

Weiterbildung

CAS Hochschuldidaktik
PHZH
08 / 2020

Netzwerk

Mitglied in Netzwerken

• biotechnet, Board Member
• EUROoCS, member of the European Organ-on-Chip Society
• Dechema, member of the scientific committee of the 3D cell culture symposium
• Animalfree Research, Foundation Board Member
• TERMIS, member of the Tissue Engineering and Regenerative Medicine International Society
• IMPSS, International Microphysiological Systems Society

ORCID digital identifier

ORCID ID: 0000-0002-4605-8190

Social Media

LinkedIn

Projekte

• Hin zu mechanisch biokompatiblen Implantatmaterialien zur Behandlung von Beckenbodensenkungen / Teammitglied / laufend
• Herstellung von Clean Meat mittels essbaren Scaffolds / Projektleiter:in / abgeschlossen
• Tumormikroumgebung 3D / Stellv. Projektleiter:in / abgeschlossen
• Bioprinting von Biofilmen / Stellv. Projektleiter:in / abgeschlossen
• 3D Gewebe TEDD / Projektleiter:in / abgeschlossen
• Transglutaminase crosslinking potential / Stellv. Projektleiter:in / abgeschlossen
• Bioprinting of vascular structures / Stellv. Projektleiter:in / abgeschlossen

Publikationen

Beiträge in wissenschaftlicher Zeitschrift, peer-reviewed

• Deshmukh, D. V. et al. (2026) 'Acoustofluidic patterning for improved microtissue histology', Advanced NanoBiomed Research, 6(4), p. e202500079. doi: 10.1002/anbr.202500079.
• Rimann, M. et al. (2022) 'Acrylonitrile and pullulan based nanofiber mats as easily accessible scaffolds for 3D skin cell models containing primary cells', Cells, 11(3), p. 445. doi: 10.3390/cells11030445.
• D'Agostino, S. et al. (2022) 'Macromolecular crowding tuned extracellular matrix deposition in a bioprinted human rhabdomyosarcoma model', Bioprinting, 27(e00213). doi: 10.1016/j.bprint.2022.e00213.
• Alave Reyes-Furrer, A. et al. (2021) 'Matrigel 3D bioprinting of contractile human skeletal muscle models recapitulating exercise and pharmacological responses', Communications Biology, 4(1), p. 1183. doi: 10.1038/s42003-021-02691-0.
• Kopanska, K. and Rimann, M. (2020) 'TEDD Competence Centre Report 2019', Chimia, 74(5), pp. 426–428. doi: 10.2533/chimia.2020.426.
• Kopanska, K. and Rimann, M. (2020) 'Swiss-Chinese cooperation for organs-on-a-chip and stem cell research', ALTEX - Alternatives to Animal Experimentation, 37(3). doi: 10.14573/altex.2006161.
• Kopanska, K. S. et al. (2019) 'Advanced in vitro models analysis', ALTEX - Alternatives to Animal Experimentation, 36(1), pp. 144–147. doi: 10.14573/altex.1812131.
• Raghunath, M. et al. (2018) 'TEDD annual meeting with 3D bioprinting workshop', Chimia, 72(1/2), pp. 76–79. doi: 10.2533/chimia.2018.76.
• Rimann, M. (2018) 'ZHAW Waedenswil : a new approach in the fight against cancer', Chimia, 72(3), pp. 166–168. doi: 10.2533/chimia.2018.166.
• Randall, M. J. et al. (2018) 'Advances in the biofabrication of 3D skin in vitro : healthy and pathological models', Frontiers in Bioengineering and Biotechnology, 6(154), p. 154. doi: 10.3389/fbioe.2018.00154.
• Laternser, S. et al. (2018) 'A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues', SLAS Technology: Translating Life Sciences Innovation, 23(6), pp. 599–613. doi: 10.1177/2472630318776594.
• Rimann, M. et al. (2015) 'Standardized 3D bioprinting of soft tissue models with human primary cells', SLAS Technology: Translating Life Sciences Innovation, 21(4), pp. 496–509. doi: 10.1177/2211068214567146.
• Rimann, M. et al. (2014) 'Automation of 3D cell culture using chemically defined hydrogels', SLAS Technology: Translating Life Sciences Innovation, 19(2), pp. 191–197. doi: 10.1177/2211068213508651.
• Fuchs, B. et al. (2014) 'An in vitro osteosarcoma 3D microtissue model for drug development', Journal of Biotechnology, 189, pp. 129–135. doi: 10.1016/j.jbiotec.2014.09.005.
• Rimann, M. et al. (2013) 'TEDD - innovation network for 3D cell cultivation : 3D cell culture for drug development', Chimia, 67(11), pp. 822–824. doi: 10.2533/chimia.2013.822.
• Rimann, M. and Graf-Hausner, U. (2012) 'Synthetic 3D multicellular systems for drug development', Current Opinion in Biotechnology, 23(5), pp. 803–809. doi: 10.1016/j.copbio.2012.01.011.

Buchbeiträge, peer-reviewed

Rimann, M., Graf-Hausner, U. and Müller, M. (2017) 'Bioresorbable polymers for bioprinting applications', in Perale, G. and Hilborn, J. (eds) Bioresorbable polymers for biomedical applications : from fundamentals to translational medicine. Amsterdam: Elsevier, pp. 331–362. doi: 10.1016/B978-0-08-100262-9.00015-X.

Schriftliche Konferenzbeiträge, peer-reviewed

Hofmann, J. et al. (2024) 'Micro and macromechanics of electrospun membranes under uniaxial and biaxial loading conditions', in 29th Congress of the European Society of Biomechanics (ESB), Edinburgh, Scotland, 30 June - 3 July 2024.

Weitere Publikationen

• Kopanska, K. S. and Rimann, M. (2022) 'Cross-industrial applications of organotypic models', ALTEX - Alternatives to Animal Experimentation, 39(1), pp. 155–158. doi: 10.14573/altex.2112202.
• Bono, E. et al. (2022) 'Automation of 3D cell culture using cellulose-based scaffolds', in Biointerfaces International Conference (BIC), Zurich, Switzerland, 12-15 September 2022. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-25998.
• Kopanska, K. S. and Rimann, M. (2021) 'TEDD annual meeting 2020 : 10th anniversary, 10 years of innovation in tissue engineering', ALTEX - Alternatives to Animal Experimentation, 38(1), pp. 166–167. doi: 10.14573/altex.2012151.
• Bono, E., Mathes, S. and Rimann, M. (2017) 'Evaluation of 3D hepatic tissue models for bioprinting', in TERMIS-EU 2017 Conference, Davos, 26-30 June 2017. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-3590.
• Bono, E. et al. (2017) 'In vitro characterization of a new composite material for biomedical applications and 3D (bio)printing', in TEDD Annual Meeting, Wädenswil, 8-9 November 2017. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-3587.
• Rimann, M. et al. (2017) 'Development of a matrix-based technology platform for the high throughput analysis of 3D cell cultures', in Swiss Medtech Day, Bern, 13 June 2017. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-3588.
• Rimann, M. et al. (2016) 'Bioprinted kidney model for nephrotoxicity assessment', in Swiss Medtech Day, Bern, 7 June 2016.
• Rimann, M. et al. (2016) 'A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues', in Swiss Medtech Day, Bern, 7 June 2016.
• Raghunath, M. et al. (2016) 'Zurich University of Applied Sciences : center for cell biology and tissue engineering', in Roche Symposium, Basel, 2016.
• Rimann, M. et al. (2016) 'Zurich university of applied sciences : center for cell biology and tissue engineering', in Roche Symposium, Basel, 2016.
• Rimann, M. et al. (2015) 'Bioprinted muscle/tendon for drug assessment', in NTN Swiss Biotech Innovation Day: The potential of industry-academia collaborations, Zug, 19 August 2015.
• Graf-Hausner, U. et al. (2015) 'A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues', in CTI Medtech Event, Bern, 8. September 2015.
• Bono, E. et al. (2014) 'Skin bioprinting : an innovative approach to produce standardized skin models on demand', in Swiss Biotech Innovation Day 2014 «the Potential of Industry-Academia Collaborations», Basel, 28 August 2014.
• Graf-Hausner, U. et al. (2014) 'A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues', in CTI Medtech Event, Bern, 2. September 2014.
• Pörtner, R. et al. (2014) 'Aktuelle Trends bei der in vitro-Substanztestung in Deutschland und in der Schweiz', BIOspektrum, 20(4), pp. 470–472. doi: 10.1007/s12268-014-0466-6.
• Rimann, M. et al. (2013) 'Skin bioprinting : an innovative approach to produce standardized skin models on demand', in CTI Medtech Event 2013, Bern, 27. August 2013.
• Rimann, M. et al. (2012) 'Cryopreservation of spherical tumor microtissues', in 3D Cell Culture 2012: Zurich, 14-16 March 2012.
• Rimann, M. et al. (2012) 'Skin bioprinting : an innovative approach to produce standardized skin models on demand', in CTI Medtech Event 2012, Luzern, 24. September 2012.
• Rimann, M. et al. (2011) 'Organomimetic skin model production based on a novel bioprinting technology', in CTI Medtech Event 2011, Bern, 23. August 2011.

Mündliche Konferenzbeiträge und Abstracts

• Hofmann, J. et al. (2024) 'Large-porous or nano-fibrous? – a mechanical perspective on implant materials for the pelvic floor', in 29th Congress of the European Society of Biomechanics (ESB), Edinburgh, Scotland, 30 June - 3 July 2024.
• Rimann, M. et al. (2017) '3D bioprinted tissue models for substance testing', in International Conference and Exhibition - Society for Laboratory Automation and Screening (SLAS 2017), Washington, USA, 4–8 February 2017.
• Rimann, M. et al. (2016) '3D models for compound testing', in 3rd 3D Models & Drug Screening Conference, Berlin, Germany, 11-12 May 2016.
• Rimann, M. et al. (2016) 'Bioprinted tissues for substance evaluation', in Biointerfaces International 2016 Conference, Zurich, 23-25 August 2016.
• Rimann, M. et al. (2016) 'Bioprinted tissue models for substance evalution', in Basel Life Science Week 2016, Basel, 19-23 September 2016.
• Rimann, M. (2016) '3D tissues and biofabrication for therapy and industrial applications', in Spiez Convergence, Spiez, 5-8 September 2016.
• Graf-Hausner, U. et al. (2016) 'A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues', in Swiss Medtech Day, Bern, 7 June 2016.
• Rimann, M. et al. (2016) '3D tissue models : new perspectives in medicine', in 2016 Conference and Exhibition for Cutting-Edge Medicine (CLINAM 9), Basel, 26-29 June 2016.
• Bono, E. et al. (2016) 'Standardized 3D bioprinting of skin models for drug development', in 4th International Cosmetic Innovation Days «Cosminnov», Orléans, France, 24-25 May 2016.
• Rimann, M. et al. (2016) 'Bioprinted tissues for substance testing', in 3D Cell Culture 2016, Freiburg, Germany, 19-21 April 2016.
• Rimann, M. et al. (2015) 'Soft tissue bioprinting in tissue engineering for drug development', in Olten Meeting 2015: Antibiotics and Bioprinting - for a better life, Biotechnet Switzerland, Olten, 18 November 2015.
• Rimann, M. and Galea, L. (2015) 'Tissue bioprinting for compound evaluation', in CTI Medtech Event, Bern, 8. September 2015.
• Rimann, M. et al. (2015) 'Bioprinted soft tissue models for compound testing', in International Conference on Biofabrication (Biofabrication 2015), Utrecht, Netherlands, 7-9 November 2015.
• Rimann, M. (2015) 'Bioprinting : break-out session', in Expert Forum on 3D printing «Changing the World one Print at a Time» - Swiss Re, Rüschlikon, 30. September 2015.
• Rimann, M. (2014) 'A 3D osteosarcoma model', in Wissenschaftliches Forum über «Challenges and Opportunities in the Development of Novel Anti-Tumor Therapies», Schlieren, September 2014.
• Rimann, M. (2014) 'Bioprinting von 3D Gewebemodellen', in 5. Kongress Industrielle Zelltechnik, Lübeck, Deutschland, 11.-12. September 2014.
• Rimann, M. (2014) '3D cell-based assays for drug de-risking', in SLAS Short course, Basel, September 2014.
• Fuchs, B. et al. (2014) 'Human 3D osteosarcoma models for drug testing', in 3D Cell Culture 2014, Freiburg, Germany, 25-27 June 2014.
• Rimann, M. (2014) 'Competence centre TEDD tissue engineering for drug development', in 15th Edition of the Swiss Soft Days (SSD), Lausanne, 2 October 2014.
• Rimann, M. (2014) 'Additive Verfahren mit biologischen Materialien', in 3D Druck und Healthtech - Healthtech Cluster Switzerland, Schwyz, 28. August 2014.
• Rimann, M. (2014) 'Bioprinting : aktueller Stand in der Forschung', in 3D Druck: Revolution in Technik, Recht und Medizin?, Winterthur, 27. August 2014.
• Bono, E. et al. (2014) 'Skin bioprinting : an approach to produce standardized skin models on demand', in DECHEMA - 3D Cell Culture 2014, Freiburg, Germany, 25-27 June 2014.
• Rimann, M. (2013) 'Automation of 3D cell cultures using defined biomimetic hydrogels', in FAST Congress, Boston, USA, 17-19 October 2013.
• Rimann, M. et al. (2012) 'Organomimetic skin model production based on a novel bioprinting technology', in 3D Cell Culture 2012: Zurich, 14-16 March 2012.

Übrige Publikationen

PubMed

Zurück